Table 1.

Study population showing age, gender, tumour size and oestrogen receptor (OeR) and progesterone receptor (PR) status

Patient	Age, years	Gender	Tumour size, mm	Focal Nodular Hyperplasia(FNH)				Surrounding normal liver tissue (controls)
				OeR nuclei staining (PS)	OeR intensity score	PRa nuclei staining (PS)	OeR nuclei staining (PS)	OeR intensity score	PRa nuclei staining (PS)
1	35	F	8	1–10%	Intermediate	0	1–10%	Intermediate	0
2	27b	F	12	1–10%	Weak	0	1–10%	Weak	0
3	40	F	21	1–10%	Weak	0	1–10%	Weak	0
4	43c	F	25	1–10%	Intermediate	0	<1%	Weak	1–10%a
5	39	F	55	1–10%	Intermediate	0	1–10%	Weak	0
6	47	M	18	11–33%	Intermediate	0	11–33%	Intermediate	0
7	45	F	11, 50	11–33%	Intermediate	0	11–33%	Intermediate	0
8	42	F	95	11–33%	Weak	<1%a	11–33%	Weak	0
9	39	F	16, 17, 18	34–66%	Intermediate	<1%a	N/A	N/A	N/A
10	34	F	25	34–66%	Intermediate	0	N/A	N/A	N/A
11	38	M	Core biopsy	>67%	Strong	0	N/A	N/A	N/A
12	30d	F	Core biopsy	>67%	Strong	0	N/A	N/A	N/A
13	26c	F	45	0	None	0	1–10%	Weak	0

F, female; M, male; N/A, not available; PCOS, polycystic ovarian syndrome; PS, proportion score.

^aNo PR intensity score but weak

^bNo PR intensity score but weak

^cNo PR intensity score but weak

^dNo PR intensity score but weak